Formestane
Alternative Names: 4-HAD; 4-Hydroxyandrostenedione; 4-OHA; AT 0931; CGP 32349; CRC 8201; CRC-82/01; Formestane IM depot injection; LentaronLatest Information Update: 19 Jul 2010
At a glance
- Originator Novartis
- Class Androstenes; Antineoplastics; Ketosteroids; Small molecules
- Mechanism of Action Aromatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Breast cancer